KalVista Pharmaceuticals
Earnings Date & Report
Last updated:
Next earnings date: 3 Sep 2025
KalVista Pharmaceuticals’s last earnings date was on 9 Jul 2025.
KalVista Pharmaceuticals stock Earnings report, Estimates & History
| 2020-12-10 | -0.7 | -0.58 |
|---|---|---|
| 2021-03-11 | -0.6 | -0.56 |
| 2021-07-13 | -0.61 | -0.65 |
| 2021-09-09 | -0.73 | -0.66 |
| 2021-12-09 | -0.78 | -0.8 |
| 2022-03-10 | -0.91 | -0.92 |
| 2022-07-07 | -1.06 | -0.98 |
| 2022-09-08 | -1.02 | -0.94 |
| 2022-12-08 | -1.04 | -0.9 |
| 2023-03-09 | -0.97 | -0.75 |
| 2023-07-07 | -0.92 | -0.77 |
| 2023-09-07 | -0.83 | -0.74 |
| 2023-12-07 | -0.71 | -0.8 |
| 2024-03-11 | -0.75 | -0.84 |
| 2024-07-11 | -0.71 | -1.02 |
| 2024-09-05 | -0.95 | -0.87 |
| 2024-12-05 | -0.91 | -0.91 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
KalVista Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 3 Sep 2025 | N/A | N/A | N/A | N/A | N/A | |
| 9 Jul 2025 | N/A | N/A | N/A | N/A | N/A | |
| 10 Mar 2025 | N/A | -$0.94 | N/A | N/A | N/A | |
| 5 Dec 2024 | Matched | -$0.91 | -$0.91 | N/A | N/A | |
| 5 Sep 2024 | Beat | -$0.95 | -$0.87 | N/A | N/A | |
| 11 Jul 2024 | Missed | -$0.71 | -$1.02 | N/A | 1.20M | |
| 11 Mar 2024 | Missed | -$0.75 | -$0.84 | N/A | N/A | |
| 7 Dec 2023 | Missed | -$0.71 | -$0.8 | N/A | N/A | |
| 7 Sep 2023 | Beat | -$0.83 | -$0.74 | N/A | N/A | |
| 7 Jul 2023 | Beat | -$0.92 | -$0.77 | N/A | N/A | |
| 9 Mar 2023 | Beat | -$0.97 | -$0.75 | N/A | N/A | |
| 8 Dec 2022 | Beat | -$1.04 | -$0.9 | N/A | N/A | |
| 8 Sep 2022 | Beat | -$1.02 | -$0.94 | N/A | N/A | |
| 7 Jul 2022 | Beat | -$1.06 | -$0.98 | N/A | N/A | |
| 10 Mar 2022 | Missed | -$0.91 | -$0.92 | N/A | N/A | |
| 9 Dec 2021 | Missed | -$0.78 | -$0.8 | N/A | N/A | |
| 9 Sep 2021 | Beat | -$0.73 | -$0.66 | N/A | N/A | |
| 13 Jul 2021 | Missed | -$0.61 | -$0.65 | N/A | 12.69M | |
| 11 Mar 2021 | Beat | -$0.6 | -$0.56 | N/A | N/A | |
| 10 Dec 2020 | Beat | -$0.7 | -$0.58 | N/A | N/A | |
KalVista Pharmaceuticals Earnings report FAQs
When is KalVista Pharmaceuticals's next Earnings date?
The next earnings date of KalVista Pharmaceuticals is on 3 Sep 2025.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.